Belgian (BEL20) Pharmaceuticals & Biotech Acciones - Los grandes perdedores de hoy
ACTUALIZADO Jan 28, 2026
Explore los Belgian (BEL20) mayores perdedores de hoy. Estos Pharmaceuticals & Biotech Stocks han experimentado la mayor caída en capitalización bursátil desde la jornada anterior.
| Empresa | Último precio | 1D Retorno | Rendimiento 1 año | Capitalización bursátil | Objetivo de los analistas | Valoración | Crecimiento | Div Rendimiento | ||
|---|---|---|---|---|---|---|---|---|---|---|
TUB | €215.00 | -3.4% | 39.2% | €9.6b | €230.50 | 103.2 | n/a | 0.5% | ||
UCB | €253.00 | -0.1% | 33.6% | €48.1b | €264.21 | 36.1 | 18.0% | 0.5% | ||
ARGX | €710.00 | -0.03% | 11.8% | €43.5b | €824.20 | 33.9 | 23.2% | n/a | ||
HYL | €8.00 | -0.7% | 50.4% | €224.0m | €13.57 | 26.5 | 79.9% | n/a | ||
OXUR | €0.0066 | -5.7% | -97.1% | €490.7k | n/a | 0.2 | n/a | n/a | ||
CYAD | €0.17 | 0% | -61.8% | €7.7m | n/a | 41.3 | n/a | n/a | ||
ALEMS | €5.20 | 0.02% | -15.4% | €22.0m | n/a | 18.8 | n/a | n/a | ||
BIOS | €0.0025 | 4.2% | -37.5% | €1.6m | n/a | -0.4 | n/a | n/a |
Page 1 of 1